Mon 04/03/2023 09:00 AM
Kyle Owusu, CFA, JD
Senior Director, High-Yield Analyst
kowusu@reorg.com
Reorg’s performing credit analysis features healthcare companies DaVita, or DVA, Select Medical, or SEM, and Tenet Healthcare, or THC.
Salient points are below:
- DVA’s 2031 bonds are being offered at about 77, providing ability for capital appreciation; the company’s credit agreement does not restrict DVA from repurchasing its 2030 or 2031 unsecured notes. Management expects $600 million to $900 million of free cash...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.